Skip to menu Skip to content Skip to footer

2018

Journal Article

PLP1 mutations in patients with multiple sclerosis: identification of a new mutation and potential pathogenicity of the mutations

Cloake, Nancy, Yan, Jun, Aminian, Atefeh, Pender, Michael and Greer, Judith (2018). PLP1 mutations in patients with multiple sclerosis: identification of a new mutation and potential pathogenicity of the mutations. Journal of Clinical Medicine, 7 (10) 342, 342. doi: 10.3390/jcm7100342

PLP1 mutations in patients with multiple sclerosis: identification of a new mutation and potential pathogenicity of the mutations

2018

Journal Article

Increased constitutive activation of NF-κB p65 (RelA) in peripheral blood cells of patients with progressive multiple sclerosis

Yan, Jun, Winterford, Clay M., Catts, Vibeke S., Pat, Betty K., Pender, Michael P., McCombe, Pamela A. and Greer, Judith M. (2018). Increased constitutive activation of NF-κB p65 (RelA) in peripheral blood cells of patients with progressive multiple sclerosis. Journal of Neuroimmunology, 320, 111-116. doi: 10.1016/j.jneuroim.2018.04.002

Increased constitutive activation of NF-κB p65 (RelA) in peripheral blood cells of patients with progressive multiple sclerosis

2018

Conference Publication

Antibodies specific for myelin proteolipid protein can inhibit remyelination in vivo

Bagert, Bridget, Greer, Judith, Savage, Hannah, Beasley, Shannon, Juba, Gracy and Pender, Michael (2018). Antibodies specific for myelin proteolipid protein can inhibit remyelination in vivo. AAN 70th Annual Meeting, Los Angeles, CA United States, 21-27 April 2018. Philadelphia, PA United States: Wolters Kluwer. doi: 10.1212/wnl.90.15_supplement.s52.001

Antibodies specific for myelin proteolipid protein can inhibit remyelination in vivo

2018

Conference Publication

Antibodies Specific for Myelin Proteolipid Protein Can Inhibit Remyelination In Vivo

Bagert, Bridget A., Greer, Judith M., Savage, Hannah, Beasley, Shannon J., Juba, Gracy and Pender, Micahel P. (2018). Antibodies Specific for Myelin Proteolipid Protein Can Inhibit Remyelination In Vivo. ACTRIMS Forum, San Diego Ca, Feb 01-03, 2018. LONDON: SAGE PUBLICATIONS LTD.

Antibodies Specific for Myelin Proteolipid Protein Can Inhibit Remyelination In Vivo

2018

Conference Publication

Antibodies specific for myelin proteolipid protein can inhibit remyelination in vivo

Bagert, Bridget, Greer, Judith, Savage, Hannah, Beasley, Shannon, Juba, Gracy and Pender, Michael (2018). Antibodies specific for myelin proteolipid protein can inhibit remyelination in vivo. 70th Annual Meeting of the American Academy of Neurology (AAN), Los Angeles, California, 21-27 April 2018. Philadelphia, PA, United States: Lippincott Williams & Wilkins.

Antibodies specific for myelin proteolipid protein can inhibit remyelination in vivo

2017

Journal Article

Novel Therapeutics for Multiple Sclerosis Designed by Parasitic Worms

Dixit, Aakanksha, Tanaka, Akane, Greer, Judith M and Donnelly, Sheila (2017). Novel Therapeutics for Multiple Sclerosis Designed by Parasitic Worms. International Journal of Molecular Sciences, 18 (10) 2141, 1-17. doi: 10.3390/ijms18102141

Novel Therapeutics for Multiple Sclerosis Designed by Parasitic Worms

2017

Journal Article

Predicting the effects of potentially therapeutic modified peptides on polyclonal T cell populations in a mouse model of multiple sclerosis

Sauer, Evan L., Trifilieff, Elisabeth and Greer, Judith M. (2017). Predicting the effects of potentially therapeutic modified peptides on polyclonal T cell populations in a mouse model of multiple sclerosis. Journal of Neuroimmunology, 307, 18-26. doi: 10.1016/j.jneuroim.2017.03.011

Predicting the effects of potentially therapeutic modified peptides on polyclonal T cell populations in a mouse model of multiple sclerosis

2017

Journal Article

Reactivity to novel autoantigens in patients with coexisting central nervous system demyelinating disease and autoimmune thyroid disease

Greer, Judith M., Broadley, Simon and Pender, Michael P. (2017). Reactivity to novel autoantigens in patients with coexisting central nervous system demyelinating disease and autoimmune thyroid disease. Frontiers in Immunology, 8 (514) 514, 514. doi: 10.3389/fimmu.2017.00514

Reactivity to novel autoantigens in patients with coexisting central nervous system demyelinating disease and autoimmune thyroid disease

2017

Conference Publication

Using a parasite derived peptide to prevent immune-mediated demyelination

Donnelly, Sheila, Greer, Judith and Dixit, Aakanksha (2017). Using a parasite derived peptide to prevent immune-mediated demyelination. Progress in MS Research Conference, Sydney Australia, 11-13 October 2017. London, United Kingdom: Sage Publications.

Using a parasite derived peptide to prevent immune-mediated demyelination

2016

Journal Article

A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis

Lund, Maria E., Greer, Judith M., Dixit, Aakanksha, Alvarado, Raquel, McCauley-Winter, Padraig, To, Joyce, Tanaka, Akane, Hutchinson, Andrew T., Robinson, Mark W., Simpson, Ann M., O'Brien, Bronwyn A., Dalton, John P. and Donnelly, Sheila (2016). A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis. Scientific Reports, 6 (1) 37789, 37789. doi: 10.1038/srep37789

A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis

2016

Journal Article

Interleukin 6 promoter 174 G/C polymorphisms in acute ischemic stroke: G allele is protective but not associated with IL-6 levels or stroke outcome

Yan, J., Greer, J. M. and McCombe, P. A. (2016). Interleukin 6 promoter 174 G/C polymorphisms in acute ischemic stroke: G allele is protective but not associated with IL-6 levels or stroke outcome. Journal of Neuroimmunology, 293, 22-27. doi: 10.1016/j.jneuroim.2016.02.001

Interleukin 6 promoter 174 G/C polymorphisms in acute ischemic stroke: G allele is protective but not associated with IL-6 levels or stroke outcome

2016

Conference Publication

Functional effects of antibodies specific for myelin proteolipid protein in multiple sclerosis

Greer, J. M., Muller, D. M., Beasley, S. J., Trifilieff, E. and Pender, M. P. (2016). Functional effects of antibodies specific for myelin proteolipid protein in multiple sclerosis. ICI 2016 International Congress of Immunology, Melbourne, Australia, 21–26 August 2016. Weinheim, Germany: Wiley.

Functional effects of antibodies specific for myelin proteolipid protein in multiple sclerosis

2016

Conference Publication

Protection against development of a mouse model of multiple sclerosis by a parasite-derived 68-mer peptide

Dixit, A., Donnelly, S., Lund, M. A., Dalton, J. P. and Greer, J. M. (2016). Protection against development of a mouse model of multiple sclerosis by a parasite-derived 68-mer peptide. ICI 2016 International Congress of Immunology, Melbourne, Australia, 21–26 August 2016. Weinheim, Germany: Wiley. doi: 10.1002/eji.201670200

Protection against development of a mouse model of multiple sclerosis by a parasite-derived 68-mer peptide

2015

Journal Article

Autoantibodies and their potential roles in diseases of the nervous system

Beasley, Shannon J. and Greer, Judith M. (2015). Autoantibodies and their potential roles in diseases of the nervous system. Clinical and Experimental Neuroimmunology, 6 (4), 370-386. doi: 10.1111/cen3.12269

Autoantibodies and their potential roles in diseases of the nervous system

2015

Journal Article

Circulating brain derived neurotrophic factor (BDNF) and frequency of BDNF positive T cells in peripheral blood in human ischemic stroke: effect on outcome

Chan, Adeline, Yan, Jun, Csurhes, Peter, Greer, Judith and McCombe, Pamela (2015). Circulating brain derived neurotrophic factor (BDNF) and frequency of BDNF positive T cells in peripheral blood in human ischemic stroke: effect on outcome. Journal of Neuroimmunology, 286, 42-47. doi: 10.1016/j.jneuroim.2015.06.013

Circulating brain derived neurotrophic factor (BDNF) and frequency of BDNF positive T cells in peripheral blood in human ischemic stroke: effect on outcome

2015

Journal Article

Taming the TCR: antigen-specific immunotherapeutic agents for autoimmune diseases

Sauer, Evan L., Cloake, Nancy C. and Greer, Judith M. (2015). Taming the TCR: antigen-specific immunotherapeutic agents for autoimmune diseases. International Reviews of Immunology, 34 (6), 460-485. doi: 10.3109/08830185.2015.1027822

Taming the TCR: antigen-specific immunotherapeutic agents for autoimmune diseases

2015

Journal Article

Characterization of a new rat model for chronic inflammatory demyelinating polyneuropathies

Brun, Susana, Beaino, Wissam, Kremer, Laurent, Taleb, Omar, Mensah-Nyagan, Ayikoe Guy, Lam, Chanh D., Greer, Judith M., de Seze, Jerome and Trifilieff, Elisabeth (2015). Characterization of a new rat model for chronic inflammatory demyelinating polyneuropathies. Journal of Neuroimmunology, 278, 1-10. doi: 10.1016/j.jneuroim.2014.11.022

Characterization of a new rat model for chronic inflammatory demyelinating polyneuropathies

2015

Conference Publication

Expression of glutamate transporter splice variants on oligodendrocytes in rat brain and in mixed glial cultures

Beasley, S., Lee, A., Greer, J. and Pow, D. (2015). Expression of glutamate transporter splice variants on oligodendrocytes in rat brain and in mixed glial cultures. 25th Biennial Meeting of the International Society for Neurochemistry Jointly with the 13th Meeting of the Asian Pacific Society for Neurochemistry in Conjunction with the 35th Meeting of the Australasian Neuroscience Society, Cairns, QLD Australia, 23-27 August 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/jnc.13188

Expression of glutamate transporter splice variants on oligodendrocytes in rat brain and in mixed glial cultures

2015

Book Chapter

The role of HLA in MS susceptibility and phenotype

Greer, Judith M. (2015). The role of HLA in MS susceptibility and phenotype. Emerging and evolving topics in multiple sclerosis pathogenesis and treatments. (pp. 1-27) edited by Anne C. La Flamme and Jacqueline Monique Orian. Heidelberg, Germany: Springer. doi: 10.1007/7854_2014_357

The role of HLA in MS susceptibility and phenotype

2014

Journal Article

Quantitative proteome profiling of CNS-infiltrating autoreactive CD4+ cells reveals selective changes during experimental autoimmune encephalomyelitis

Turvey, Michelle E., Koudelka, Tomas, Comerford, Iain, Greer, Judith M., Carroll, William, Bernard, Claude C. A., Hoffmann, Peter and McColl, Shaun R. (2014). Quantitative proteome profiling of CNS-infiltrating autoreactive CD4+ cells reveals selective changes during experimental autoimmune encephalomyelitis. Journal of Proteome Research, 13 (8), 3655-3670. doi: 10.1021/pr500158r

Quantitative proteome profiling of CNS-infiltrating autoreactive CD4+ cells reveals selective changes during experimental autoimmune encephalomyelitis